scout
|Videos|August 16, 2017

Challenges With PARP Inhibitors in Ovarian Cancer

Kathleen N. Moore, MD, assistant professor in the section of gynecologic oncology and director of the Oklahoma TSET Phase I Clinical Trials Program at the University of Oklahoma Health Sciences Center, discusses challenges with PARP inhibitors in ovarian cancer.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME